229 Furthermore, 5-HT6R signaling was found to be associated with changes in cholinergic and glutamatergic functions in the brain, with little peripheral effect.230 However, the clinical trials against AD revealed no evidence for the therapeutic activity of any of the selective 5-HT6R or 5-HT7R drugs.57 The gene discussed is HTR6; the disease is Alzheimer disease.